CPC Scientific Inc.

About CPC Scientific Inc.

CPC Scientific is a globally recognized and leading CDMO specializing in synthetic peptide production. We work directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. We boast the largest peptide facility in the world, which successfully has undergone multiple FDA inspections and audits by global pharma organizati...

Certifications
  • US
  • 2016
    On CPHI since
  • 3
    Certificates
Company types
Contract Service
Contact info

Products from CPC Scientific Inc. (3)

  • Generic Peptides

    Product Generic Peptides

    GMP-grade peptide APIs AVAILABLE GENERIC PEPTIDES: • Bivalirudin trifluoroacetate • Eptifibatide acetate • Exenatide acetate • Glatiramer acetate • Glucagon acetate • Glucagon hydrochloride • Glucagon-like peptide • Gonadorelin acetate • Goserelin acetate • Leuprolide acet...
  • GMP Peptide Manufacturing

    Product GMP Peptide Manufacturing

    With more than a decade of committed service to the peptide industry, CPC Scientific is a trusted provider of high-quality peptides to researchers and pharmaceutical companies all over the world. The CPC Group is comprised of peptide experts who have actively pursued peptide design and large scale ...
  • Catalog Peptides

    Product Catalog Peptides

    CPC Scientific provides high-quality, ready-to-use peptides to make your life easier by increasing your efficiency and reducing your costs. Each month, we unveil our latest peptides designed for your most urgent research needs. Many of these peptides have been frequently cited in the lite rature...

CPC Scientific Inc. Resources (1)

  • News Terlipressin Formulation with API Manufactured by CPC Scientific Approved for Further Study by the MEB

    SAN JOSE, CA., Feb 1, 2021 /CPCNewswire/ — CPC Scientific Inc. is pleased to announce that the Dutch Medicines Evaluation Board (MEB) has completed its technical review of their client’s drug product and formulation process for Terlipressin. The API provided to the client is manufactured at CPC Scientific’s GMP facility. On January 18, 2021, the MEB granted approval of the drug product and will move to the next phase to review product characterization profiles, specifications, and labels in the Netherlands. The MEB is the Dutch regulatory agency responsible for assessing, monitoring, and promoting the proper use of medicines. After final approval, the drug product will be available for sale in the Netherlands and Germany.